Lancet Regional Health-Western Pacific is a premier academic journal published by Elsevier, focusing on the diverse and dynamic field of health in the Western Pacific region. With an impressive Q1 ranking across several vital categories such as Geriatrics and Gerontology, Health Policy, Infectious Diseases, and Public Health, this journal is positioned at the forefront of health research and policy development. The journal aims to provide a platform for innovative research, reviews, and opinion pieces that lead to improved health outcomes and influence health policy across this geographically and culturally rich area. Offering open access to its content, Lancet Regional Health-Western Pacific ensures that the latest findings are readily available to researchers, professionals, and policymakers alike, ultimately contributing to the global discourse on health issues. As it continually strives to maintain rigorous publication standards, the journal serves as a crucial resource in promoting evidence-based practices and driving advancements in public health.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Kesmas-National Public Health Journal is a vital platform for the dissemination of research in the field of public health, published by UNIV INDONESIA. With its ISSN of 1907-7505 and E-ISSN of 2460-0601, this Open Access journal has been committed to promoting accessible health knowledge since 2006. Based in Indonesia, the journal addresses critical areas of public health, including epidemiology, health policy, and environmental health, with the aim to foster health improvements in diverse communities. Despite its classification in the Q4 category across several important fields as of 2023, including Epidemiology and Public Health, the journal remains a unique resource for local and international researchers seeking to contribute to pressing public health issues. With its Scopus rankings reflecting persistent challenges within the discipline, Kesmas invites researchers, professionals, and students to engage with its content to drive impactful discussions and advancements in health policy and practice.

Travel Medicine and Infectious Disease is a premier peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of travel medicine and infectious disease research. With an impressive impact factor and a category ranking of Q1 in both Infectious Diseases and Public Health, Environmental and Occupational Health, this journal is recognized as a leading source of high-quality research and insights. Originating in 2003 and transitioning to an Open Access model in 2023, it aims to disseminate critical findings that enhance the understanding of health risks associated with travel, vaccination strategies, and infectious disease outbreaks. The journal’s Scopus rankings reflect its influence, with a rank of 7/665 in Public Health and 20/344 in Infectious Diseases. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest trends and developments in travel-related health challenges.

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Journal of Infection and Public Health is a premier open-access journal published by ELSEVIER SCIENCE LONDON, dedicated to advancing knowledge in the fields of infectious diseases, public health, and environmental health. Since its inception in 2008, this esteemed journal has become a cornerstone of research dissemination, especially after transitioning to an open-access model in 2017, allowing wider accessibility to groundbreaking studies. With an impressive impact factor and ranking in the Q1 category for Infectious Diseases and Public Health as of 2023, the journal stands at the forefront of scientific inquiry, boasting a Scopus rank of #22 out of 665 in Public Health, underscoring its influence and reach in the academic community. Researchers, professionals, and students alike will find the journal's rich repository of peer-reviewed articles invaluable for ongoing education and practice in a rapidly evolving field. For contributing to the global understanding of health dynamics, Journal of Infection and Public Health is a vital resource, inviting scholars to explore, engage, and contribute to the crucial discussions shaping our world.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

Welcome to Transboundary and Emerging Diseases, a prestigious journal published by WILEY-HINDAWI. With its ISSN of 1865-1674 and E-ISSN of 1865-1682, this journal plays a pivotal role in the dissemination of high-quality research within the fields of Immunology, Microbiology, Medicine, and Veterinary Sciences. Based in the United Kingdom, this open-access journal stands out with a remarkable impact factor, reflecting its category quartiles in 2023, where it secured Q1 rankings across multiple disciplines, including a remarkable rank of #3 out of 194 in Veterinary General, placing it in the top 2% of its field. With coverage spanning from 2008 to 2024, Transboundary and Emerging Diseases provides a vital platform for researchers, professionals, and students to explore emerging threats to global health and animal welfare. The journal's commitment to open access ensures broad availability of cutting-edge research, fostering collaboration and knowledge sharing in pursuit of innovative solutions to transboundary diseases. Join a community dedicated to advancing the science and practice within this crucial area of study.

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.